This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)
By Matthew Perrone
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV. Under the FDA approval, babies — including preterm infants — can receive a single injection to protect against their first season of RSV, which typically lasts about five months. Children up to age 2 can receive another dose to protect them during their second season facing the virus.
Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did not immediately announce the U.S. price of the treatment.
FDA officials approved the drug based on three studies showing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger.
Advisers to the Centers for Disease Control and Prevention will meet early next month to recommend exactly who should get the drug.
A similar antibody drug won FDA approval more than 20 years ago, but it’s only recommended for high-risk babies and requires monthly injections. Pediatricians say the drug is underutilized and they expect the longer-lasting effect of AstraZeneca's shot to improve uptake.
In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
After decades of setbacks for RSV research, drugmakers have made big strides this year, launching the first vaccines against the virus. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Waseem Asghar, Ph.D., Associate Professor, Department of Computer & Electrical Engineering and Computer Science, Florida Atlantic University, joins Cheddar Reveals to break down the latest progress, trends, and innovations in wearable health tech.
Washington DC and the surrounding areas saw a record breaking snow storm Monday as a strong storm system works its way across the eastern U.S. The extreme weather event caused extensive damage in the greater Washington area, leaving thousands in the region without power. Jonathan Porter, Chief Meteorologist, AccuWeather, joined Wake Up with Cheddar to discuss the fierce storm.
Sweta Chakraborty, U.S. President of We Don't Have Time and climate change expert, joins Cheddar News to discuss how mining the proper resources for the clean energy sector is crucial.
Over the past year alone, we've seen an increasing push-back on fossil fuels, legislation to reduce plastic pollution, greater protection over our worlds' forests, and a growing number of companies working to reduce total carbon footprint. To discuss the sustainability trends that defined 2021 and the changes individuals can make in 2022, J.D. Durkin is joined by Ashlee Piper, a sustainability expert and author of 'Give a Sh*t: Do Good. Live Better. Save the Planet,' joins Cheddar News.
Experts say that at some point next year, the pandemic will officially drop its pandemic status, becoming endemic. While this is a milestone to acknowledge, it does not mean we're free of infections, illnesses, and deaths. Dr. Rajeev Fernando, infectious disease specialist, Beth Israel Hospital and fellow, joins Cheddar News' Closing Bell to discuss.
Chicago-based Internist Dr. Vivek Cherian joined Wake Up With Cheddar to break down the unprecedented surge in U.S. COVID-19 as many prepare to celebrate the new year.
Dr. Soumi Eachempati, co-founder and CEO of Cleared4 and former professor of surgery and public health at Weill Cornell Medical College, joined Cheddar to breakdown what people should know about the recently FDA-approved emergency use of Merck and Pfizer's COVID-19 treatment pills. He noted that not only do people need to be aware of other medications they are taking that could cause adverse effects if coupled with COVID-19 pill treatments, he also talked about the intense in-take regiment. "The Merck pills are actually about 40 pills over five days. The Pfizer ones are three pills over five days, so people have to be prepared for that because it is a lot of pills you'll have to take to get full value from these drugs," Eachempati told Cheddar.
Twitter is exploding with a new meme after the CDC revised its Covid-19 guidelines, shortening the recommended isolation period to five days instead of 10 for when you test positive and are asymptomatic. The change came amid a skyrocketing surge of new cases is the U.S. due to the Omicron variant, drawing criticism from experts and Twitter --with users claiming the government agency is giving funny advise on a variety of issues. But what does the meme say about the public’s trust in the agency? Cheddar News speaks with political strategist Hastie Afkhami.
